{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifiskqrmgw37j37otd32gexhd7rjnef6qmrnmw4uuyr6m53sec3dy",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3ml2dzanwk552"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibjyyqhl634qz3lvxpq2hrkqkuhhrg44ohd7jdi2yzos4inpkqiui"
    },
    "mimeType": "image/jpeg",
    "size": 408612
  },
  "path": "/2026/05/04/well/abortion-pill-mifepristone-supreme-court-louisiana.html",
  "publishedAt": "2026-05-04T17:58:59.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Abortion",
    "Telemedicine",
    "Mifeprex (RU-486)",
    "Abortion Drugs"
  ],
  "textContent": "The Louisiana lawsuit, which seeks to block telehealth prescribing and mailing of the abortion pill mifepristone, has major implications for abortion access nationwide.",
  "title": "Mifepristone, the Abortion Pill, Returns to the Supreme Court. Here’s What to Know."
}